Results 281 to 290 of about 591,464 (366)

The use of denosumab in rare bone diseases in adults: a systematic review from the ECTS Rare Bone Disease Action Group.

J Clin Endocrinol Metab
Bulaicon OO, van Haalen FM, Clunie GPR, Grasemann C, Lems WF, Makras P, Mortier G, Oheim R, Raimann A, Siggelkow H, Tabacco G, van der Wal RJP, de Witte PB, Appelman-Dijkstra NM.   +13 more
europepmc   +1 more source

Clinical Outcomes and Exploratory Longitudinal CTL/Vβ Repertoire Remodeling in Patients with Relapsed or Refractory Large B-Cell Lymphoma and Follicular Lymphoma Treated with Epcoritamab. [PDF]

Int J Mol Sci
Jo T, Taguchi J, Sawayama Y, Matsuo M, Umemoto K, Yamaguchi K, Noguchi K, Sakai T, Ikegami S, Baba R, Inoue T, Irie S, Abe K, Shigematsu K, Miyazaki Y.   +14 more
europepmc   +1 more source

Quizartinib in Combination With FLAG‐IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG‐QUIDA): A PETHEMA Phase I‐II Trial

American Journal of Hematology, EarlyView.
ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal, Javier Zambrano Márquez, Rebeca Rodríguez‐Veiga, Eduardo Rodríguez‐Arbolí, Juan Manuel Bergua‐Burgués, Susana Vives, Montserrat Arnán, Pilar Martínez Sánchez, Pilar Herrera‐Puente, Josefina Serrano‐López, Vicente Rubio, Inmaculada Marchante‐Cepillo, Marta Cervera‐Calvo, Andrés Novo García, Rosa Fernández Martín, Cristina Gil Cortés, Carlos Rodríguez‐Medina, Victor Noriega‐Concepción, Ana Alfonso‐Piérola, Carmen Loredo, María Antuña‐Casal, Blanca Boluda, Isabel Cano‐Ferri, Evelyn Acuña‐Cruz, Laura Torres‐Miñana, Joaquín Sánchez‐García, Cristina Bilbao, Maria Teresa Gómez‐Casares, David Martínez Cuadrón, Pau Montesinos   +29 more
wiley   +1 more source

Discontinuation of SGLT2i After a Urogenital Infection: A Population-Based Matched Cohort Study of Patients With Type 2 Diabetes. [PDF]

Diabetes Obes Metab
Ljungberg C, Nørgaard M, Vandenbroucke-Grauls C, Dalager-Pedersen M, Sørensen HT, Thomsen RW.   +5 more
europepmc   +1 more source

Clinical Predictors of Response in Chronic Graft‐Versus‐Host Disease: Results From the “Predicting the Quality of Response to Specific Treatments (PQRST)” Trial

American Journal of Hematology, EarlyView.
ABSTRACT Despite significant progress in chronic GVHD therapies, challenges remain in understanding pleomorphic phenotypes and varying responses to treatment. The aim of this study was to identify predictors of treatment response. We conducted a prospective, observational cohort study of patients beginning first‐, second‐, or third‐line systemic ...
Betty K. Hamilton, Lynn Onstad, Paul A. Carpenter, Joseph Pidala, George Chen, Corey Cutler, Najla El Jurdi, Nosha Farhadfar, Mark Juckett, Carrie L. Kitko, Catherine J. Lee, Stephanie J. Lee   +11 more
wiley   +1 more source

Hockman A, Anuskiewicz S, Brennan E, et al. Efficacy of eculizumab discontinuation in atypical hemolytic uremic syndrome: a systematic review and meta-analysis. Blood Adv. 2025;9(23):6096-6107. [PDF]

Blood Adv
europepmc   +1 more source

Discrepancies between declared and real practices of continuous renal replacement therapy for septic acute kidney injury in French intensive care units. [PDF]

Ann Intensive Care
Stephan L, Prevel R, Sazio C, Ilciukas-Miquel H, Auvet A, Bodot S, Chelha R, Coirier V, Fabre X, Garin A, Garraud J, Gisbert-Mora C, Grillet G, Hayon J, Labro G, Lambour A, Lancrey-Javal T, Le Basnier E, Mikulski M, Nicolas J, Olry K, Plouvier F, Seguin T, Tientcheu A, Valette M, Guisset O, Gruson D, Boyer A, Orieux A.   +28 more
europepmc   +1 more source

Dordaviprone Maintenance After Allogeneic HCT for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Neoplasm

American Journal of Hematology, EarlyView.
ABSTRACT Dordaviprone is a first‐in‐class small‐molecule imipridone. In preclinical studies, it is active against leukemia cells harboring a TP53 mutation or complex karyotype and leukemia stem cells while sparing normal bone marrow cells. This study aimed to determine the safety of dordaviprone maintenance after allogeneic hematopoietic cell ...
Vijaya Raj Bhatt, Christopher S. Wichman, Alyssa Bouska, Moataz Ellithi, Michael Haddadin, Javeed Iqbal, James E. Talmadge, Lori J. Maness, Krishna Gundabolu   +8 more
wiley   +1 more source

Help‐Seeking and Substance Use Among Police Staff After the 2018 Strasbourg Christmas Market Attack

American Journal of Industrial Medicine, EarlyView.
ABSTRACT Background The use of mental health services by police staff is usually low. After the 2018 attack on the Strasbourg Christmas market, police officers exposed to psychotraumatic risks were found to have a higher PTSD risk. This study aims to describe the help‐seeking and substance use by police staff after the attack.
Nathalie Nourry, Ludivine Nohales, Laurence Lalanne, Emmanuel Fort, Maria Gonzalez, Pierre Vidailhet, Amaury C. Mengin, Barbara Charbotel   +7 more
wiley   +1 more source